Methylprednisolone suleptanate
磺庚甲泼尼龙
Report date: 2025/11/17 10:08:13
NME
Base Information
Drug NameMethylprednisolone suleptanate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGu Research Network Llc
Active IndicationsN/A
Inactive Indications